cp wire

CP Wire Articles

China Approves Gilead's Genvoya for HIV-1 Infection
  • Genvoya is the first TAF-based single tablet regimen for the treatment of HIV to be approved in China
  • There were approximately 140,000 people newly diagnosed with HIV in China as of... read more
Mon, 08/6/18 - 09:35 am
Harpoon Therapeutics Begins Trial of Novel Immuno-Oncololgy Drug in Patients with Metastatic Castration-Resistant Prostate Cancer
  • Clinical data expected in 2019
  • HPN424 is designed as an ‘off-the-shelf’ T cell therapy
  • HPN424 serum half-life of 80 hours supporting once-weekly administration
... read more
Mon, 08/6/18 - 09:20 am
Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile in Ph II Trial
  • Ridinilazole treatment resulted in a 59% reduction in recurrence compared to vancomycin
  • C. difficile causes approximately 500,000 infections and 29,000 deaths in the US... read more
Fri, 08/3/18 - 10:03 am
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
  • Selumetinib granted Orphan Status by the FDA in 2018
  • NF1 gene mutation occurs in approximately one in 3,000 births
  • Array Biopharma claims AZ owes approximately $192 million... read more
Fri, 08/3/18 - 09:23 am
The UK's MHRA Grants Early Access to Anlylam's Patisiran



Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced on 8/3/18 that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has... read more

Fri, 08/3/18 - 09:01 am

Pages